about
New water-soluble ruthenium(II) terpyridine complexes for anticancer activity: synthesis, characterization, activation kinetics, and interaction with guanine derivatives.The unprecedented bridging coordination mode of 1,1-cyclobutane dicarboxylate (mu-cbdc-O,O') stabilized by intramolecular hydrogen bonds in ruthenium(II) complexes.Replacement of chlorides with dicarboxylate ligands in anticancer active Ru(II)-DMSO compounds: a new strategy that might lead to improved activity.1-(2-Picolyl)-substituted 1,2,3-triazole as novel chelating ligand for the preparation of ruthenium complexes with potential anticancer activity.A categorization of metal anticancer compounds based on their mode of action.Kinetic and mechanistic study on the reactions of ruthenium(ii) chlorophenyl terpyridine complexes with nucleobases, oligonucleotides and DNA.New uses for old drugs: attempts to convert quinolone antibacterials into potential anticancer agents containing ruthenium.Factors that influence the antiproliferative activity of half sandwich Ru(II)-[9]aneS3 coordination compounds: activation kinetics and interaction with guanine derivatives.New half sandwich Ru(II) coordination compounds for anticancer activity.New half sandwich-type Ru(II) coordination compounds characterized by the fac-Ru(dmso-S)3 fragment: influence of the face-capping group on the chemical behavior and in vitro anticancer activity.Ruthenium-porphyrin conjugates with cytotoxic and phototoxic antitumor activity.Half-sandwich Ru II[9]aneS3 complexes structurally similar to antitumor-active organometallic piano-stool compounds: preparation, structural characterization and in vitro cytotoxic activity.Synthetic strategies towards ruthenium-porphyrin conjugates for anticancer activity.Impact of aromaticity on anticancer activity of polypyridyl ruthenium(II) complexes: synthesis, structure, DNA/protein binding, lipophilicity and anticancer activity.New 4'-(4-chlorophenyl)-2,2':6',2″-terpyridine ruthenium(II) complexes: Synthesis, characterization, interaction with DNA/BSA and cytotoxicity studies.Influence of the anionic ligands on the anticancer activity of Ru(II)-dmso complexes: Kinetics of aquation and in vitro cytotoxicity of new dicarboxylate compounds in comparison with their chloride precursors.New cationic and neutral Ru(II)- and Os(II)-dmso carbonyl compounds.Heterometallic In(III)–Pd(II) Porous Metal–Organic Framework with Square-Octahedron Topology Displaying High CO2 Uptake and Selectivity toward CH4 and N2Photolabile RuIIHalf-Sandwich Complexes Suitable for Developing “Caged” Compounds: Chemical Investigation and Unexpected Dinuclear Species with Bridging Diamine LigandsNew gold pincer-type complexes: synthesis, characterization, DNA binding studies and cytotoxicityExceptional gravimetric and volumetric CO2 uptake in a palladated NbO-type MOF utilizing cooperative acidic and basic, metal–CO2 interactionsEnhanced gas-sorption properties of a high surface area, ultramicroporous magnesium formateDesign of photoactivatable metallodrugs: Selective and rapid light-induced ligand dissociation from half-sandwich [Ru([9]aneS3)(N–N′)(py)]2+ complexesNew ruthenium(II) precursors with the tetradentate sulfur macrocycles tetrathiacyclododecane ([12]aneS4) and tetrathiacyclohexadecane ([16]aneS4) for the construction of metal-mediated supramolecular assembliesHalf-sandwich RuII-[9]aneS3 complexes with dicarboxylate ligands: synthesis, characterization and chemical behaviorMetalloporphyrins as chemical shift reagents: the unambiguous NMR characterization of the cis- and trans-isomers of meso-(bis)-4′-pyridyl-(bis)-4′-carboxymethylphenylporphyrinsRuthenium Anticancer Compounds: Challenges and ExpectationsPreparation, Structure Determination and Cytotoxicity of the PdII·Bleomycin A2 ComplexStructural studies on metallobleomycins: The interaction of Pt(II) and Pd(II) with bleomycinHigh-resolution crystal structures of a "half sandwich"-type Ru(II) coordination compound bound to hen egg-white lysozyme and proteinase K
P50
Q30828082-CE79C856-CF48-4474-B190-A20870D7A80DQ31021081-780E445C-02DD-4C04-8BBB-3D16A5074688Q33270506-AEBD3340-DC5B-44A7-812F-C74B60D358D5Q33862825-1EE40D0F-2DF3-4948-AA47-4A307A3198DBQ37598545-AF876844-96AC-4B6A-B87D-1BAA13CCC013Q38289233-E017FC50-7FCC-4868-91F8-1C60F638BC43Q39120504-DC6B7557-020C-4B6F-951E-51698547772AQ39295123-8DDE7C5C-F175-4BB6-9BD3-A04F385E9651Q39349142-85FA2FF2-72EF-4C23-8ACE-BFE41239A767Q39488143-248F6522-5DB3-43E7-BBE0-5553BFB3ACCBQ39701624-40DDD6D7-D837-4625-8373-643F084D4DADQ40012492-E035CBD8-5020-449C-9B71-CE4A8A028C38Q43214171-1B33C35B-528E-4152-9124-AD2FAD1A9E58Q46337807-8717545F-CCE2-4F7A-B561-E36F1B60B3B9Q46432615-FC409863-170E-4934-A3BA-BA2D0B59BF64Q46863423-5F7F1225-3ECD-4838-A86F-E92EA8F4323BQ46987605-656D4036-24BD-4919-B225-57C88FFA5620Q57501957-61C8F81B-4CCA-4CE4-AB3E-E6A78410FA8DQ57502124-5F974F11-37C0-4510-8DDC-CB6BC95AD0EDQ57507111-B5F4147A-1D83-4F6E-9EC1-1F51BA50F04CQ57507115-3192D5C9-9BDF-489D-B077-313BEB2167C6Q57507123-8B4DD65C-2956-470C-A896-EE53AD537F6AQ57507127-92874E1F-4C8F-4098-A64B-8C1745CFE303Q57507135-9C1551D5-23E9-45FD-8D74-5ECF92C158A5Q57507138-2A94C895-78C7-43E6-B45E-A4F06EEA724BQ57507142-4D44108B-FF3C-4C0E-9B08-98F67492A660Q57507152-C725CB25-CD00-4590-84A1-E44F102168DFQ57507158-F4DDCAB8-6232-408E-A8A4-4AB429EB3123Q57507161-0A1EB11F-DF8D-4542-8682-1555A5735489Q91716269-99701292-0CA6-4F0C-A6C7-B0BB0A52F9C2
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ioannis Bratsos
@ast
Ioannis Bratsos
@en
Ioannis Bratsos
@es
Ioannis Bratsos
@nl
Ioannis Bratsos
@sl
type
label
Ioannis Bratsos
@ast
Ioannis Bratsos
@en
Ioannis Bratsos
@es
Ioannis Bratsos
@nl
Ioannis Bratsos
@sl
prefLabel
Ioannis Bratsos
@ast
Ioannis Bratsos
@en
Ioannis Bratsos
@es
Ioannis Bratsos
@nl
Ioannis Bratsos
@sl
P1053
J-6996-2014
P106
P1153
23023926000
P21
P31
P3829
P496
0000-0002-9787-5481